Flow Cytometry Market
The global flow cytometry market was estimated at USD 4.5 billion in 2017, and is projected to register a CAGR of over 8.2% from 2018 to 2025. Increasing prevalence of target disease, growing adoption of flow cytometry in advanced research activities, and continuous technological advancement in the clinical research field are key growth drivers for the global flow cytometry market. The replacement of conventional instruments and high demand for point-of-care testing are expected to boost the growth of the global flow cytometry market.
North America accounted to be the largest region in the flow cytometry market, owing to research and advancement of technology and increasing acceptance of flow cytometry. In addition, there is rapid development in life science and clinical sector in countries such as the U.S. and Canada that also contribute to the growth. These factors are the key growth drivers for flow cytometry market in North America.
The major strategic developments by key market players have been placed in the following: -
In January 2016, Bio-Rad Laboratories and Illumina, Inc. announced their partnership to develop the comprehensive next generation sequencing (NGS) workflow for single-cell analysis. The sequencing solution enables high-throughput of sequencing of thousands of individual cells.
In January 2018, ThermoFisher Scientific launched Attune NxT flow cytometer system. The system is incorporated with hydrodynamic focusing technology and offers rapid and accurate analysis for a broad range of samples.
Figure 1: Global Flow Cytometry Market Share, By Application, 2017 (USD Million)
The increasing demand from application industries such as research, clinical, and industrial applications is driving the growth in the flow cytometry market. Clinical applications segment is estimated to hold the largest share. However, the research application segment is estimated to be the fastest growing application; this growth is attributed to the increasing acceptance of flow cytometry in wide range of applications.
Scope of the Study
- Flow Cytometry Market, by Technology
- Cell-Based Flow Cytometry
- Bead-Based Flow Cytometry
- Flow Cytometry Market, by Product Type
- Reagents and Consumables
- Flow Cytometry Instruments
- Services
- Software
- Accessories
- Flow Cytometry Market, by Application
- Research Applications
- Pharmaceutical & Biotechnology
- Immunology
- Cell Sorting
- Apoptosis
- Others
- Clinical Applications
- Cancer
- Hematology
- Organ Transplantation
- Others
- Industrial Applications
- Research Applications
- Flow Cytometry Market, by Region
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
This report provides an in depth analysis of key companies and competitive analysis of developments recorded in the industry in the last eight years. In this report, market dynamics such drivers, barriers, opportunities, challenge, and factor analysis has been discussed in detail. Key market players such as Danaher, ThermoFisher Scientific, Merck KGaA, Bio-Rad Laboratories, and Becton, Dickson and Company have been profiled to provide an insight into the competitive scenario of the global flow cytometry market. Leading manufacturers of flow cytometry are focusing on expansions and joint ventures; through this the companies aim to increase their market reach and customer base.
1. Market Introduction
1.1. Key Research Objectives
1.2. Market Definition
1.3. Report Scope
1.3.1. Segmental Scope
1.3.2. Regional Scope
1.4. Currency & Conversions
1.5. Research Assumptions & Limitations
1.5.1. Assumptions
1.5.2. Limitations
2. Research Methodology
2.1. Market Size Estimation
2.2. Market Breakdown & Data Triangulation
2.3. Sources
2.3.1. Key Secondary Sources
2.3.2. Key Primary Sources
2.3.3. Key Industry Insights
3. Executive Summary
3.1. Overview
3.2. By Technology
3.3. The reagents and consumables segment is estimated to be the largest segment by product type
3.4. The research application segment is expected to be the fastest growing application segment.
3.5. North America is estimated to be the largest region for flow cytometry market
3.6. Leading strategic developments
3.7. Market Life Cycle Analysis
4. Market Overview
4.1. Market Dynamics
4.1.1. Factor Analysis
4.1.1.1. Parent Market Analysis
4.1.1.2. Demand-Side Analysis
4.1.1.3. Supply-Side Analysis
4.1.2. Drivers
4.1.3. Barriers
4.1.4. Opportunities
4.1.5. Challenges
4.2. Global Flow Cytometry Market Scenario
4.2.1. Global Flow Cytometry Market, by Technology
4.2.2. Global Flow Cytometry Market, by Product Type
4.2.3. Global Flow Cytometry Market, by Application
4.2.4. Global Flow Cytometry Market, by Region
5. Industry Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.3. Strategic Benchmarking
5.4. Regulatory Framework
6. Global Flow cytometry Market, By Technology
6.1. Cell-Based Flow Cytometry
6.1.1. By Region
6.2. Bead-Based Flow Cytometry
6.2.1. By Region
7. Global Flow cytometry Market, By Product Type
7.1. Reagents and Consumables
7.1.1. By Region
7.2. Flow Cytometry Instruments
7.2.1. By Region
7.3. Services
7.3.1. By Region
7.4. Software
7.4.1. By Region
7.5. Accessories
7.5.1. By Region
8. Global Flow cytometry Market, Application
8.1. Research Applications
8.1.1. Pharmaceutical & Biotechnology
8.1.2. Immunology
8.1.3. Cell Sorting
8.1.4. Apoptosis
8.1.5. Others
8.1.6. By Region
8.2. Clinical Applications
8.2.1. Cancer
8.2.2. Hematology
8.2.3. Organ Transplantation
8.2.4. Others
8.2.5. By Region
8.3. Industrial Applications
8.3.1. By Region
9. Global Flow cytometry Market, By Region
9.1. North America
9.1.1. By Country
9.1.2. By Technology
9.1.3. By Product Type
9.1.4. By Applications
9.1.5. Key Country-wise Insights
9.1.5.1. US
9.1.5.1.1. By Technology
9.1.5.1.2. By Product Type
9.1.5.1.3. By Application
9.1.5.2. Canada
9.1.5.2.1. By Technology
9.1.5.2.2. By Product Type
9.1.5.2.3. By Application
9.1.5.3. Mexico
9.1.5.3.1. By Technology
9.1.5.3.2. By Product Type
9.1.5.3.3. By Application
9.2. Europe
9.2.1. By Country
9.2.2. By Technology
9.2.3. By Product Type
9.2.4. By Applications
9.2.5. Key Country-wise Insights
9.2.5.1. Germany
9.2.5.1.1. By Technology
9.2.5.1.2. By Product Type
9.2.5.1.3. By Application
9.2.5.2. France
9.2.5.2.1. By Technology
9.2.5.2.2. By Product Type
9.2.5.2.3. By Application
9.2.5.3. UK
9.2.5.3.1. By Technology
9.2.5.3.2. By Product Type
9.2.5.3.3. By Application
9.2.5.3.4.
9.2.5.4. Italy
9.2.5.4.1. By Technology
9.2.5.4.2. By Product Type
9.2.5.4.3. By Application
9.2.5.4.4.
9.2.5.5. Rest of the Europe
9.2.5.5.1. By Technology
9.2.5.5.2. By Product Type
9.2.5.5.3. By Application
9.3. Asia-Pacific
9.3.1. By Country
9.3.2. By Technology
9.3.3. By Product Type
9.3.4. By Applications
9.3.5. Key Country-wise Insights
9.3.5.1. China
9.3.5.1.1. By Technology
9.3.5.1.2. By Product Type
9.3.5.1.3. By Application
9.3.5.2. Japan
9.3.5.2.1. By Technology
9.3.5.2.2. By Product Type
9.3.5.2.3. By Application
9.3.5.3. India
9.3.5.3.1. By Technology
9.3.5.3.2. By Product Type
9.3.5.3.3. By Application
9.3.5.4. Malaysia
9.3.5.4.1. By Technology
9.3.5.4.2. By Product Type
9.3.5.4.3. By Application
9.3.5.5. Rest of the Asia-Pacific
9.3.5.5.1. By Technology
9.3.5.5.2. By Product Type
9.3.5.5.3. By Application
9.4. Middle East & Africa
9.4.1. By Country
9.4.2. By Technology
9.4.3. By Product Type
9.4.4. By Applications
9.4.5. Key Country-wise Insights
9.4.5.1. UAE
9.4.5.1.1. By Technology
9.4.5.1.2. By Product Type
9.4.5.1.3. By Application
9.4.5.2. Saudi Arabia
9.4.5.2.1. By Technology
9.4.5.2.2. By Product Type
9.4.5.2.3. By Application
9.4.5.3. Rest of Middle East & Africa
9.4.5.3.1. By Technology
9.4.5.3.2. By Product Type
9.4.5.3.3. By Application
9.5. South America
9.5.1. By Country
9.5.2. By Technology
9.5.3. By Product Type
9.5.4. By Applications
9.5.5. Key Country-wise Insights
9.5.5.1. Brazil
9.5.5.1.1. By Technology
9.5.5.1.2. By Product Type
9.5.5.1.3. By Application
9.5.5.2. Argentina
9.5.5.2.1. By Technology
9.5.5.2.2. By Product Type
9.5.5.2.3. By Application
9.5.5.2.4.
9.5.5.3. Rest of South America
9.5.5.3.1. By Technology
9.5.5.3.2. By Product Type
9.5.5.3.3. By Application
10. Competitive Landscape
10.1. Market Share Analysis
10.2. Key Strategic Developments
10.2.1. Overview
10.2.2. Mergers & Acquisitions
10.2.3. Expansions & Investments
10.2.4. New Product Developments
10.3. Competitive Matrix
11. Company Profiles
11.1. Introduction
11.2. Danaher
11.2.1. Company Overview
11.2.2. Product Portfolio
11.2.3. SWOT Analysis
11.2.4. Strategic Development Activities
11.2.5. Converged Markets’ View
11.3. Becton, Dickinson and Company
11.3.1. Company Overview
11.3.2. Product Portfolio
11.3.3. SWOT Analysis
11.3.4. Strategic Development Activities
11.3.5. Converged Markets’ View
11.4. ThermoFisher Scientific
11.4.1. Company Overview
11.4.2. Product Portfolio
11.4.3. SWOT Analysis
11.4.4. Strategic Development Activities
11.4.5. Converged Markets’ View
11.5. Merck KGaA
11.5.1. Company Overview
11.5.2. Product Portfolio
11.5.3. SWOT Analysis
11.5.4. Strategic Development Activities
11.5.5. Converged Markets’ View
11.6. Bio-Rad Laboratories
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. SWOT Analysis
11.6.4. Strategic Development Activities
11.6.5. Converged Markets’ View
11.7. Miltenyi Biotec
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. SWOT Analysis
11.7.4. Strategic Development Activities
11.7.5. Converged Markets’ View
11.8. Sysmex Corporation
11.8.1. Company Overview
11.8.2. Product Portfolio
11.8.3. SWOT Analysis
11.8.4. Strategic Development Activities
11.8.5. Converged Markets’ View
11.9. Luminex
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. SWOT Analysis
11.9.4. Strategic Development Activities
11.9.5. Converged Markets’ View
11.10. Agilent Technologies
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. SWOT Analysis
11.10.4. Strategic Development Activities
11.10.5. Converged Markets’ View
11.11. Sony Biotechnology
11.11.1. Company Overview
11.11.2. Product Portfolio
11.11.3. SWOT Analysis
11.11.4. Strategic Development Activities
11.11.5. Converged Markets’ View
11.12. Acea Bioscience
11.12.1. Company Overview
11.12.2. Product Portfolio
11.12.3. SWOT Analysis
11.12.4. Strategic Development Activities
11.12.5. Converged Markets’ View
11.13. Enzo Life Sciences
11.13.1. Company Overview
11.13.2. Product Portfolio
11.13.3. SWOT Analysis
11.13.4. Strategic Development Activities
11.13.5. Converged Markets’ View
12. Appendix
12.1. Discussion Guide
12.2. Additional Customizations
12.3. Disclaimer
The global flow cytometry market was valued at USD 4.5 billion in 2017, and is estimated to register a CAGR of over 8.2% from 2018 to 2025. Flow cytometry is a laser/impedance-based biophysical technology. The key growth drivers for the global flow cytometry market are continues technological advancement, increasing research activities in the field of life sciences, and increasing clinical applications of flow cytometry.
The flow cytometry market is segmented on the basis of technology, product type, and application. The two major technologies are cell-based flow cytometry and bead-based flow cytometry. The product type segment includes reagents and consumables, flow cytometry instruments, services, software, and accessories. The applications include, research applications, clinical applications, and industrial applications.
On the basis of technology, the bead-based flow cytometry is expected witness highest growth during the forecast period. The growth is attributed to the advantages offered by this technology such as, capacity to detect multiple analytes, stability, speed, and high reproducibility.
By the product segment, reagents and consumables is estimated to hold the largest share, owing to the increasing demand for flow cytometry in pharmaceuticals, biotechnology, and clinical research.
In the application segments, the clinical application is estimated to witness the highest growth during the forecast period. The growth of the segment is attributed to the increasing usage of flow cytometry in clinical applications such as, organ transplantation, cancer diagnosis, and other disorder treatments.
North America is estimated to be the largest region for the flow cytometry market. Primary factors contributing to the growth are rapid technological advancements, high R&D; investments, and wide use of flow cytometry.
The key players in this market include, Danaher, ThermoFisher Scientific, Merck KGaA, Bio-Rad Laboratories, and Becton, Dickson and Company.
In July 2017, Danaher (Beckman Coulter Danaher) launched its latest clinical flow system product, Navios Ex flow cytometer. This new product delivers accurate and high complexity results using Tetra reagents. The Navios Ex has the advanced optics and laser technology.
In January 2016, Bio-Rad Laboratories acquired a high performance analytical flow cytometer platform from Propel Labs. Through this development the company aims to advance in basic and multi-parameter cytometry for a wide range of applications.
Figure 1: Global Flow Cytometry Market by Region, 2017 (USD Million)
On the basis of region, North America holds the largest share for the global flow cytometry market. However, Asia-Pacific is estimate to be the fastest growing application owing to the increasing research activities in the developing countries such as, China, India, and Japan.
